Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaafar Bennouna

Showing results (1-10 of 169) with videos related to

Pageof 17
Sort By:
Journal of Medical Imaging and Radiation Sciences|November 14, 2019
Impact of Air Gap on Intensity-Modulated Proton Therapy Breast PlansSuresh Rana, Jaafar Bennouna
Physical and Engineering Sciences in Medicine|October 7, 2020
Investigating beam matching for multi-room pencil beam scanning proton therapySuresh Rana, Jaafar Bennouna
Current Oncology (Toronto, Ont.)|October 27, 2022
Treatments for Non-Small-Cell Lung Cancer: The Multiple Options for Precision MedicineElvire Pons-Tostivint, Jaafar Bennouna
Cancer Management and Research|December 16, 2020
Osimertinib for Front-Line Treatment of Locally Advanced or Metastatic <i>EGFR</i>-Mutant NSCLC Patients: Efficacy, Acquired Resistance and Perspectives for Subsequent TreatmentsMarc G Denis, Jaafar Bennouna
Expert Review of Anticancer Therapy|August 26, 2003
Prospects for colorectal cancer treatment: oral chemotherapy and targeted biotherapyJaafar Bennouna, Jean-Yves Douillard
Future Oncology (London, England)|November 26, 2015
Afatinib-based combination regimens for the treatment of solid tumors: rationale, emerging strategies and recent progressJaafar Bennouna, Shanti Ricardo Moreno Vera
Oncology (Williston Park, N.Y.)|May 17, 2002
Update on European adjuvant trials with irinotecan for colorectal cancerJean-Yves Douillard, Veronique Barbarot, Jaafar Bennouna
Oncology|March 21, 2009
The role of UFT in metastatic colorectal cancerJaafar Bennouna, Mark Saunders, Jean-Yves Douillard
Clinical Colorectal Cancer|July 16, 2008
Is XELOX equivalent to FOLFOX or other continuous-infusion 5-fluorouracil chemotherapy in metastatic colorectal cancer?Jean-Yves Douillard, Jaafar Bennouna, Helene Senellart
Expert Review of Anticancer Therapy|April 18, 2020
EGFR mutation-positive NSCLC: factors to consider when deciding first-line therapyPauline Hulo, Dahna Coupez, Marc G Denis, et al.
Pageof 17

Showing results (1-10 of 169) with videos related to

Sort By:
Pageof 17
Journal of Medical Imaging and Radiation Sciences|November 14, 2019
Impact of Air Gap on Intensity-Modulated Proton Therapy Breast PlansSuresh Rana, Jaafar Bennouna
Physical and Engineering Sciences in Medicine|October 7, 2020
Investigating beam matching for multi-room pencil beam scanning proton therapySuresh Rana, Jaafar Bennouna
Current Oncology (Toronto, Ont.)|October 27, 2022
Treatments for Non-Small-Cell Lung Cancer: The Multiple Options for Precision MedicineElvire Pons-Tostivint, Jaafar Bennouna
Cancer Management and Research|December 16, 2020
Osimertinib for Front-Line Treatment of Locally Advanced or Metastatic <i>EGFR</i>-Mutant NSCLC Patients: Efficacy, Acquired Resistance and Perspectives for Subsequent TreatmentsMarc G Denis, Jaafar Bennouna
Expert Review of Anticancer Therapy|August 26, 2003
Prospects for colorectal cancer treatment: oral chemotherapy and targeted biotherapyJaafar Bennouna, Jean-Yves Douillard
Future Oncology (London, England)|November 26, 2015
Afatinib-based combination regimens for the treatment of solid tumors: rationale, emerging strategies and recent progressJaafar Bennouna, Shanti Ricardo Moreno Vera
Oncology (Williston Park, N.Y.)|May 17, 2002
Update on European adjuvant trials with irinotecan for colorectal cancerJean-Yves Douillard, Veronique Barbarot, Jaafar Bennouna
Oncology|March 21, 2009
The role of UFT in metastatic colorectal cancerJaafar Bennouna, Mark Saunders, Jean-Yves Douillard
Clinical Colorectal Cancer|July 16, 2008
Is XELOX equivalent to FOLFOX or other continuous-infusion 5-fluorouracil chemotherapy in metastatic colorectal cancer?Jean-Yves Douillard, Jaafar Bennouna, Helene Senellart
Expert Review of Anticancer Therapy|April 18, 2020
EGFR mutation-positive NSCLC: factors to consider when deciding first-line therapyPauline Hulo, Dahna Coupez, Marc G Denis, et al.
Pageof 17